Edwards, J. (2019) Glasgow Royal Infirmary Prostate Cancer array. [Data Collection]

Collection description

This database was established to allow us to investigate biomarkers in prostate cancer.

Safehaven number: GSH/18/ON006

Ninety patients with hormone-naive prostate cancer samples available were recruited at the Glasgow Royal Infirmary between 1992 and 2002. Last date of follow-up was 11/01/2012. Patients gave written consent. Clinical data included age, Gleason score, tumour lymphovascular invasion (LVI), serum PSA levels at diagnosis, biochemical recurrence, serum PSA at biochemical recurrence and presence of metastases. Patients were considered to have biochemical recurrence dependent on treatment; radical prostatectomy serum PSA >0.2 ng ml−1, radical radiotherapy serum PSA of 2.0 ng ml−1 above the post-treatment nadir level, hormone treatment 2–3 consecutive rises in serum PSA levels above the nadir obtained at intervals of >2 weeks. Study end points were biochemical relapse, survival from biochemical relapse and disease-specific survival.

West of Scotland Research Ethics Committee approved the study (reference: 05/S0704/94)

College / School:	College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Date Deposited:	15 Apr 2019 11:04
URI:	https://researchdata.gla.ac.uk/id/eprint/782
Additional details Additional details Dataset URL: https://www.nhsggc.org.uk/about-us/professional-support-sites/nhsggc-safe-haven/ Type of data: Other Date: 15 April 2019 Additional information: This study was supported by funding from the Association of International Cancer Research, Think Pink and NHS Greater Glasgow and Clyde Research Endowment Fund. This is a metadata-only record. To access the data associated with this record, please contact the NHSGGC Safehaven. The accession number for this dataset is GSH/18/ON006 Resource language: English Data Publisher: NHS Greater Glasgow and Clyde Safehaven Last Modified: 15 Apr 2019 11:31

Repository Staff Only: Update this record